Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review
November 2019
49
About the Report
About the Report
Ypsomed Holding AG (YPSN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description-A detailed description of the company's operations and business divisions.
- Corporate strategy-Analyst's summarization of the company's business strategy.
- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history-Progression of key events associated with the company.
- Major products and services-A list of major products, services and brands of the company.
- Key competitors-A list of key competitors to the company.
- Key employees-A list of the key executives of the company.
- Executive biographies-A brief summary of the executives' employment history.
- Key operational heads-A list of personnel heading key departments/functions.
- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design and development projects, flexible prototyping, human factors engineering, and IP landscape management to manufacturing and assembly infrastructure and registration support. Ypsomed offers solutions to physicians, pharmaceutical and biotechnology companies. The company's products find application in the treatment of diabetes, infertility, growth disorders and various other clinical indications. The company operates through subsidiaries and distributors across the world. Ypsomed is headquartered in Burgdorf, Switzerland.
Ypsomed Holding AG Key Recent Developments
Aug 30,2019: Ypsomed expands headquarters in Burgdorf
Aug 22,2019: Ypsomed opens production plant in Schwerin
May 23,2019: Ypsomed increases EBIT and invests in long-term profitability
Nov 06,2018: Ypsomed grows strongly with own products
Jun 29,2018: Topping-out ceremony at the new Ypsomed site in Schwerin
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Ypsomed Holding AG , SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Sanofi
Novo Nordisk AS
Medtronic Plc
Johnson & Johnson
F. Hoffmann-La Roche Ltd
Eli Lilly and Co
Abbott Laboratories
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1-About the Company
Ypsomed Holding AG-Key Facts
Ypsomed Holding AG-Key Employees
Ypsomed Holding AG-Key Employee Biographies
Ypsomed Holding AG-Major Products and Services
Ypsomed Holding AG-History
Ypsomed Holding AG-Company Statement
Ypsomed Holding AG-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2-Company Analysis
Company Overview
Ypsomed Holding AG-Business Description
Business Segment: Others
Overview
Performance
Business Segment: Ypsomed Delivery Systems
Overview
Performance
Business Segment: Ypsomed Diabetes Care
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: North America
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: Switzerland
Performance
R&D Overview
Ypsomed Holding AG-Corporate Strategy
Ypsomed Holding AG-SWOT Analysis
SWOT Analysis-Overview
Ypsomed Holding AG-Strengths
Ypsomed Holding AG-Weaknesses
Ypsomed Holding AG-Opportunities
Ypsomed Holding AG-Threats
Ypsomed Holding AG-Key Competitors
Section 3-Company Financial Ratios
Financial Ratios-Capital Market Ratios
Financial Ratios-Annual Ratios
Performance Chart
Financial Performance
Financial Ratios-Interim Ratios
Financial Ratios-Ratio Charts
Section 4-Company's Lifesciences Financial Deals and Alliances
Ypsomed Holding AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
Ypsomed Holding AG, Medical Equipment, Deals By Type, 2013 to YTD 2019
Ypsomed Holding AG, Recent Deals Summary
Section 5-Company's Recent Developments
Aug 30, 2019: Ypsomed expands headquarters in Burgdorf
Aug 22, 2019: Ypsomed opens production plant in Schwerin
May 23, 2019: Ypsomed increases EBIT and invests in long-term profitability
Nov 06, 2018: Ypsomed grows strongly with own products
Jun 29, 2018: Topping-out ceremony at the new Ypsomed site in Schwerin
Jun 27, 2018: Change in the Board of Directors of the Ypsomed Group
May 24, 2018: Ypsomed significantly increases turnover and invests more in the future
Section 6-Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Ypsomed Holding AG, Performance Chart (2015-2019)
Ypsomed Holding AG, Ratio Charts
Ypsomed Holding AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
Ypsomed Holding AG, Medical Equipment, Deals by Type, 2013 to YTD 2019
List of Table
List of Tables
Ypsomed Holding AG, Key Facts
Ypsomed Holding AG, Key Employees
Ypsomed Holding AG, Key Employee Biographies
Ypsomed Holding AG, Major Products and Services
Ypsomed Holding AG, History
Ypsomed Holding AG, Subsidiaries
Ypsomed Holding AG, Key Competitors
Ypsomed Holding AG, Ratios based on current share price
Ypsomed Holding AG, Annual Ratios
Ypsomed Holding AG, Annual Ratios (Cont...1)
Ypsomed Holding AG, Annual Ratios (Cont...2)
Ypsomed Holding AG, Interim Ratios
Ypsomed Holding AG, Medical Equipment, Deals By Year, 2013 to YTD 2019
Ypsomed Holding AG, Medical Equipment, Deals By Type, 2013 to YTD 2019
Ypsomed Holding AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.